Background: In liver transplant (LT) recipients, immunosuppressive therapy may potentially
increase the risk of severe COVID-19 and may increase the mortality in patients. However …

Despite the remarkable success of endocrine therapy in the treatment of patients with
estrogen receptor (ER)-positive breast cancer, not all patients derive benefit from such …

While leukemic cells are susceptible to various therapeutic insults, residence in the bone
marrow microenvironment typically confers protection from a wide range of drugs. Thus …

Introduction Metronomic chemotherapy (mCHT) is a treatment regimen in which drugs are
administered frequently or continuously and that maintains low, prolonged, and …

The circadian timing system controls many biological functions in mammals including
xenobiotic metabolism, detoxification, cell proliferation, apoptosis and immune functions …

A benzene-poly-carboxylic acid complex with cis-diammineplatinum (II) dihydrocholride, BP-
C1 is currently used in clinical trials in treating metastatic breast cancer. BP-C1 controls …

Tuberous sclerosis complex (TSC) is a rare, hereditary, multisystemic disease with a broad
phenotypic spectrum. Its management requires the collaboration of multiple specialists. Just …

Purpose Peptide receptor radionuclide therapy (PRRT) with [177 Lu] Lu-DOTA 0, TYR 3-
octreotate ([177 Lu] Lu-DOTA-TATE) and the mechanistic target of rapamycin (mTOR) …

Introduction: Solid cancer patients are frequently admitted in intensive care units for critical
events. Improving survival rates in this setting is considered an achievable goal today …

Background: Everolimus, an inhibitor of mammalian target of rapamycin (mTOR) used for the
treatment of various solid tumors, is associated with anemia, which can lead to morbidity and …